Loading patent…
OwnerMarc ELOIT, Philippe PEROT +9inventors
InventorsMarc ELOIT, Philippe PEROT, Beatrice REGNAULT, Nicolas DA ROCHA, Anne JAMET, Jacques FOURGEAUD, Marianne LERUEZ-VILLE, Agnes FERRONI, Olivier LORTHOLARY, Claire ROUZAUD, Delphine CHRETIEN
Estimating the term…
The invention relates to the discovery of the first pathogenic human circovirus in samples from a human hepatitis patient, the capsid of which shows only 39% identity at the amino acid level with the closest known circovirus. This discovery allows for the generation of recombinant nucleic acids, primers, peptides, probes, antibodies, immunogenic compositions, and diagnostic assays specific for human circovirus.
A recombinant nucleic acid comprising a human circovirus 1 (HCirV-1) nucleotide sequence, said sequence comprising SEQ ID NO:
A primer or probe comprising at least 10 successive nucleotides of SEQ ID NO:
(canceled)
(canceled)
(canceled)
An isolated protein or peptide comprising at least 15 amino acids of SEQ ID NO:
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.